Shift of Clinical Human Immunodeficiency Virus Type 1 Isolates from X4 to R5 and Prevention of Emergence of the Syncytium-Inducing Phenotype by Blockade of CXCR4

Documenti analoghi

• The CXCR4 Antagonist AMD3100 Efficiently Inhibits Cell-Surface-Expressed Human Immunodeficiency Virus Type 1 Envelope-Induced Apoptosis
  di: Blanco, Julià, et al.
  Pubblicazione: (2000)
• Interleukin-7 in Plasma Correlates with CD4 T-Cell Depletion and May Be Associated with Emergence of Syncytium-Inducing Variants in Human Immunodeficiency Virus Type 1-Positive Individuals
  di: Llano, Anuska, et al.
  Pubblicazione: (2001)
• Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
  di: Schols, Dominique, et al.
  Pubblicazione: (1997)
• Bicyclams, Selective Antagonists of the Human Chemokine Receptor CXCR4, Potently Inhibit Feline Immunodeficiency Virus Replication
  di: Egberink, Herman F., et al.
  Pubblicazione: (1999)
• Modest Human Immunodeficiency Virus Coreceptor Function of CXCR3 Is Strongly Enhanced by Mimicking the CXCR4 Ligand Binding Pocket in the CXCR3 Receptor
  di: Hatse, Sigrid, et al.
  Pubblicazione: (2007)